AVR 6.45% $12.22 anteris technologies ltd

"Take a Closer Look", page-648

  1. 2,434 Posts.
    lightbulb Created with Sketch. 393
    Hey sb, could you clarify your last sentence mate 'I know surgeons and they will demand the best for their patients '
    It seems in contradiction to one : the slow take up of the CardioCel in years past, two: their conservative nature in taking up new products/technology.

    It has also been mentioned in the past where medical companies have offered 'incentives' to medical practitioners to keep using their 'product'!

    Suckii .... It is also a sad fact that some of these companies will still pass off their surplus products (that have failed in Western countries) to 3 rd World countries ...

    Lex .... what next! I think what will happen in the next 5 to 10 years will surpass anything we could imagine, will Ahz become one of many emerging bios to be part of this!

    Hope that WP can marry the science Ahz has to the business model we need to take full advantage of all existing and future IP.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.